by jlohrconsulting | Aug 28, 2025 | Uncategorized
ACR Open Rheumatol. 2025 Sep;7(9):e70089. doi: 10.1002/acr2.70089. ABSTRACT OBJECTIVE: To explore the cerebrospinal fluid (CSF) proteome in systemic lupus erythematosus (SLE) and the associations between the CSF proteomic patterns and clinical manifestations. METHODS:...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
J Atten Disord. 2025 Aug 28:10870547251364575. doi: 10.1177/10870547251364575. Online ahead of print. ABSTRACT AIM: Assess prevalence and correlates of cannabis use in adults with attention-deficit/hyperactivity disorder (ADHD) and explore its impact on comorbidities,...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
J Psychopharmacol. 2025 Aug 28:2698811251364389. doi: 10.1177/02698811251364389. Online ahead of print. ABSTRACT BACKGROUND: The optimal lumateperone dose for bipolar depression remains uncertain. AIMS: To examine its dose-response relationship for efficacy and...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
J Man Manip Ther. 2025 Aug 28:1-10. doi: 10.1080/10669817.2025.2553040. Online ahead of print. ABSTRACT BACKGROUND: Cervicogenic headache is a common condition frequently associated with cervical spine disorders. It significantly impairs physical and psychological...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
Neuropsychiatr Dis Treat. 2025 Aug 22;21:1731-1750. doi: 10.2147/NDT.S532027. eCollection 2025. ABSTRACT Parkinson’s disease (PD) has been recognized for more than two centuries. Historically viewed as a clinicopathological entity, PD may have diverse genetic or...
Recent Comments